Open labelled, single arm, interventional study of hair serum for premature greying of hair
Not Applicable
Completed
- Conditions
- Health Condition 1: L679- Hair color and hair shaft abnormality, unspecified
- Registration Number
- CTRI/2022/04/041679
- Lead Sponsor
- Apex laboratories private limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
1.Patients aged less than 25 years diagnosed with premature canities attending the OPD
2.Patients who are willing to appear for regular follow ups and follow the prescribed treatment regularly.
3.Parents/guardians (legally authorized representative [LAR]) willing to provide written informed consent for patients aged less than 18 years. Patients between 18-25 years of age willing to provide written informed consent
Exclusion Criteria
1.Patients known to be allergic to any of the components of the study medications.
2.History of any chronic systemic disease
3.Patients with known malignancy or those on chemotherapy.
4.Refusal to participate in the study.
5.Participated in a clinical trial in last 90 days
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the efficacy of hair serum containing Greyverse, Euk 134 and <br/ ><br>Amisol trio in premature greying of hairTimepoint: after 3 months
- Secondary Outcome Measures
Name Time Method Clinical photographs â?? taken in same position and with uniform illumination. Trichoscopy with video-dermoscope (Fotofinder) before and at the end of study period (Day 0 and 90) to analyse the outcomeTimepoint: after 3 months